Virtual Series Event 2: What are industry’s top priorities? Uncovering new immuno-oncology innovations

JavaScript isn't enabled in your browser, so this file can't be opened. Enable and reload.

Virtual Series Event 2: What are industry’s top priorities? Uncovering new immuno-oncology innovations

In this two-part event, we'll be running academic partnering opportunities with leading academic institutes to discuss the immuno-oncology projects that they are currently seeking collaboration on.

- Part 1 | The Institute of Cancer Research (ICR)
- Part 2 | National Cancer Institute (NCI)

- Chair: Anabel Bennett, Communications and Campaigns Manager at IN-PART

Sign in to Google to save your progress. Learn more

* Indicates required question

Email *

Your email

Submit your questions in advance of the webinar: *

Your answer

Submit

Clear form

Never submit passwords through Google Forms.

This form was created inside of IN-PART Ltd. Report Abuse